Literature DB >> 3409168

Plasma tetranectin is reduced in cancer and related to metastasia.

B A Jensen1, I Clemmensen.   

Abstract

Tetranectin, a recently identified and characterized human plasma protein related to the fibrinolytic system, was significantly reduced in patients with various malignancies. Plasma tetranectin, measured by enzyme-linked immunosorbent assay (ELISA), was a significant discriminator regarding metastatic or nonmetastatic cancer. It had a high predictive specificity (0.93) and sensitivity (0.75) and only misclassified 14% of patients. Tetranectin may be related to the pathogenetically important processes leading to cancer spread and metastasis. In this respect, it may prove to be of discriminative importance clinically.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3409168     DOI： 10.1002/1097-0142(19880901)62:5<869::aid-cncr2820620503>3.0.co;2-6

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  12 in total

1.  Tetranectin in slow intra- and extrafusal chicken muscle fibers.

Authors:  X Xu; B Gilpin; K Iba; A Maier; E Engvall; R Albrechtsen; U M Wewer
Journal:  J Muscle Res Cell Motil       Date:  2001       Impact factor: 2.698

2.  Mice with a targeted deletion of the tetranectin gene exhibit a spinal deformity.

Authors:  K Iba; M E Durkin; L Johnsen; E Hunziker; K Damgaard-Pedersen; H Zhang; E Engvall; R Albrechtsen; U M Wewer
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

3.  Discovering collectively informative descriptors from high-throughput experiments.

Authors:  Clark D Jeffries; William O Ward; Diana O Perkins; Fred A Wright
Journal:  BMC Bioinformatics       Date:  2009-12-18       Impact factor: 3.169

4.  Identification of tetranectin as a potential biomarker for metastatic oral cancer.

Authors:  Martha E Arellano-Garcia; Roger Li; Xiaojun Liu; Yongming Xie; Xiaofei Yan; Joseph A Loo; Shen Hu
Journal:  Int J Mol Sci       Date:  2010-09-02       Impact factor: 5.923

5.  Differences in tetranectin immunoreactivity between benign and malignant breast tissue.

Authors:  L Christensen; I Clemmensen
Journal:  Histochemistry       Date:  1991

6.  Mouse tetranectin: cDNA sequence, tissue-specific expression, and chromosomal mapping.

Authors:  K Ibaraki; C A Kozak; U M Wewer; R Albrechtsen; M F Young
Journal:  Mamm Genome       Date:  1995-10       Impact factor: 2.957

7.  Aberrant tetranectin expression in human breast carcinomas as a predictor of survival.

Authors:  P Obrist; G Spizzo; C Ensinger; D Fong; T Brunhuber; G Schäfer; M Varga; R Margreiter; A Amberger; G Gastl; M Christiansen
Journal:  J Clin Pathol       Date:  2004-04       Impact factor: 3.411

8.  Exome-wide Association Study Identifies CLEC3B Missense Variant p.S106G as Being Associated With Extreme Longevity in East Asian Populations.

Authors:  Kumpei Tanisawa; Yasumichi Arai; Nobuyoshi Hirose; Hiroshi Shimokata; Yoshiji Yamada; Hisashi Kawai; Motonaga Kojima; Shuichi Obuchi; Hirohiko Hirano; Hideyo Yoshida; Hiroyuki Suzuki; Yoshinori Fujiwara; Kazushige Ihara; Maki Sugaya; Tomio Arai; Seijiro Mori; Motoji Sawabe; Noriko Sato; Masaaki Muramatsu; Mitsuru Higuchi; Yao-Wen Liu; Qing-Peng Kong; Masashi Tanaka
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-03-01       Impact factor: 6.053

9.  A potential role for tetranectin in mineralization during osteogenesis.

Authors:  U M Wewer; K Ibaraki; P Schjørring; M E Durkin; M F Young; R Albrechtsen
Journal:  J Cell Biol       Date:  1994-12       Impact factor: 10.539

10.  Tetranectin Binds to the Kringle 1-4 Form of Angiostatin and Modifies Its Functional Activity.

Authors:  Tirsit Mogues; Michael Etzerodt; Crystal Hall; Georg Engelich; Jonas H. Graversen; Kevan L. Hartshorn
Journal:  J Biomed Biotechnol       Date:  2004
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.